FIELD: medicine, phthisiology. SUBSTANCE: immunomodulator Glutoxym is introduced, at least, once daily at 30-60 mg/d, moreover, in case of pulmonary tuberculosis with predominantly exudative type of tissue reaction Glutaxym should be introduced intramuscularly twice daily per 1 ml 3-% solution; at pulmonary tuberculosis with predominantly productive type of tissue reaction Glutoxym is introduced intramuscularly twice daily per 1 ml 1-% solution thrice weekly; at pulmonary tuberculosis at the background of medicinal mycobacterial resistance Glutoxym is introduced twice daily per 1 ml 3-% solution: in the morning - intravenously, in the evening - intramuscularly for 2 mo daily. The invention considerably decreases hepatotoxic action of antitubercular preparations and increases efficiency of antitubercular chemotherapy conducted. EFFECT: higher efficiency of therapy. 5 cl, 6 ex, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF IMMUNOCORRECTION OF MAIN COURSE OF TREATMENT OF DESTRUCTIVE FORMS OF PULMONARY TUBERCULOSIS | 2012 |
|
RU2480206C1 |
METHOD FOR TREATING HUMAN TUBERCULOSIS | 2002 |
|
RU2238091C2 |
COFORMULATED ANTITUBERCULOUS DRUG | 2009 |
|
RU2430724C2 |
METHOD OF TREATING TUBERCULOSIS WITH MULTIPLE DRUG RESISTANCE | 2013 |
|
RU2554753C2 |
METHOD OF TREATING PATIENTS SUFFERING PULMONARY TUBERCULOSIS | 2012 |
|
RU2491077C1 |
METHOD FOR DECREASING RESISTANCE OF TUBERCULAR MYCOBACTERIA TO RIFAMPICIN AND ETHAMEBUTOL IN AN EXPERIMENT | 1999 |
|
RU2185162C2 |
COMBINED ANTITUBERCULAR PREPARATION AND METHOD FOR ITS OBTAINING | 2001 |
|
RU2182483C1 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2010 |
|
RU2468802C2 |
PULMONARY TUBERCULOSIS TREATMENT METHOD | 2002 |
|
RU2195313C1 |
Authors
Dates
2003-02-10—Published
2001-11-14—Filed